Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $110M (100.0% shares, 0.0% debt)

Holdings (22)

ARGX ARGENX SE 13.6%

Value $14.92M Shares 39,370 Est. Cost $378.89 Unrealized —

— MEDAVAIL HOLDINGS INC 8.2%

Value $9.019M Shares 5,894,897 Est. Cost $8.23 Unrealized —

COGT COGENT BIOSCIENCES INC 7.0%

Value $7.733M Shares 857,352 Est. Cost $10.99 Unrealized -37.9%

LNTH LANTHEUS HLDGS INC 6.9%

Value $7.593M Shares 115,000 Est. Cost $26.60 Unrealized +137.0%

GH GUARDANT HEALTH INC 5.9%

Value $6.454M Shares 160,000 Est. Cost $91.40 Unrealized -45.8%

— IVERIC BIO INC 5.7%

Value $6.253M Shares 650,000 Est. Cost $16.55 Unrealized —

GOSS GOSSAMER BIO INC 5.3%

Value $5.859M Shares 700,000 Est. Cost $8.34 Unrealized -7.1%

VRDN VIRIDIAN THERAPEUTICS INC 5.2%

Value $5.739M Shares 496,012 Est. Cost $18.20 Unrealized -26.2%

FATE FATE THERAPEUTICS INC 4.1%

Value $4.498M Shares 181,500 Est. Cost $63.35 Unrealized -56.4%

— CEREVEL THERAPEUTICS HLDNG I 4.1%

Value $4.495M Shares 170,000 Est. Cost $35.01 Unrealized —

— CHINOOK THERAPEUTICS INC 4.0%

Value $4.373M Shares 250,000 Est. Cost $17.49 Unrealized —

NUVB NUVATION BIO INC 3.4%

Value $3.684M Shares 1,137,152 Est. Cost $11.18 Unrealized -61.0%

— ISOPLEXIS CORP 3.2%

Value $3.564M Shares 1,650,118 Est. Cost $9.19 Unrealized —

— SOMALOGIC INC 3.0%

Value $3.322M Shares 735,000 Est. Cost $12.39 Unrealized —

— SYROS PHARMACEUTICALS INC 3.0%

Value $3.239M Shares 3,364,895 Est. Cost $9.70 Unrealized —

— DICE THERAPEUTICS INC 2.9%

Value $3.217M Shares 207,290 Est. Cost $15.52 Unrealized —

RLMD RELMADA THERAPEUTICS INC 2.8%

Value $3.038M Shares 160,000 Est. Cost $21.81 Unrealized 0.0%

RPID RAPID MICRO BIOSYSTEMS INC 2.7%

Value $3.009M Shares 699,664 Est. Cost $15.69 Unrealized -70.3%

NAUT NAUTILUS BIOTECHNOLOGY INC 2.6%

Value $2.907M Shares 1,080,566 Est. Cost $10.83 Unrealized -65.6%

— SCIENCE 37 HOLDINGS INC 2.6%

Value $2.834M Shares 1,410,155 Est. Cost $2.01 Unrealized —

STOK STOKE THERAPEUTICS INC 2.1%

Value $2.312M Shares 175,000 Est. Cost $23.86 Unrealized -36.3%

— JOUNCE THERAPEUTICS INC 1.5%

Value $1.667M Shares 550,000 Est. Cost $8.35 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ARGX	ARGENX SE	39,370	$14.92M	13.6%	$378.89	—	SPONSORED ADR	04016X101
—	MEDAVAIL HOLDINGS INC	5,894,897	$9.019M	8.2%	$8.23	—	COM	58406B103
COGT	COGENT BIOSCIENCES INC	857,352	$7.733M	7.0%	$10.99	-37.9%	COM	19240Q201
LNTH	LANTHEUS HLDGS INC	115,000	$7.593M	6.9%	$26.60	+137.0%	COM	516544103
GH	GUARDANT HEALTH INC	160,000	$6.454M	5.9%	$91.40	-45.8%	COM	40131M109
—	IVERIC BIO INC	650,000	$6.253M	5.7%	$16.55	—	COM	46583P102
GOSS	GOSSAMER BIO INC	700,000	$5.859M	5.3%	$8.34	-7.1%	COM	38341P102
VRDN	VIRIDIAN THERAPEUTICS INC	496,012	$5.739M	5.2%	$18.20	-26.2%	COM	92790C104
FATE	FATE THERAPEUTICS INC	181,500	$4.498M	4.1%	$63.35	-56.4%	COM	31189P102
—	CEREVEL THERAPEUTICS HLDNG I	170,000	$4.495M	4.1%	$35.01	—	COM	15678U128
—	CHINOOK THERAPEUTICS INC	250,000	$4.373M	4.0%	$17.49	—	COM	16961L106
NUVB	NUVATION BIO INC	1,137,152	$3.684M	3.4%	$11.18	-61.0%	COM CL A	67080N101
—	ISOPLEXIS CORP	1,650,118	$3.564M	3.2%	$9.19	—	COM	465005106
—	SOMALOGIC INC	735,000	$3.322M	3.0%	$12.39	—	CLASS A COM	83444K105
—	SYROS PHARMACEUTICALS INC	3,364,895	$3.239M	3.0%	$9.70	—	COM	87184Q107
—	DICE THERAPEUTICS INC	207,290	$3.217M	2.9%	$15.52	—	COM	23345J104
RLMD	RELMADA THERAPEUTICS INC	160,000	$3.038M	2.8%	$21.81	0.0%	COM	75955J402
RPID	RAPID MICRO BIOSYSTEMS INC	699,664	$3.009M	2.7%	$15.69	-70.3%	CLASS A COM	75340L104
NAUT	NAUTILUS BIOTECHNOLOGY INC	1,080,566	$2.907M	2.6%	$10.83	-65.6%	COM	63909J108
—	SCIENCE 37 HOLDINGS INC	1,410,155	$2.834M	2.6%	$2.01	—	COM	808644108
STOK	STOKE THERAPEUTICS INC	175,000	$2.312M	2.1%	$23.86	-36.3%	COM	86150R107
—	JOUNCE THERAPEUTICS INC	550,000	$1.667M	1.5%	$8.35	—	COM	481116101